Gabapentin and Daklinza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin and Daklinza. Common interactions include fatigue among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people who take Gabapentin and Daklinza have. It is created by eHealthMe based on reports of 39 people who take Gabapentin and Daklinza from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 07, 2023

39 people who take Gabapentin and Daklinza together, and have interactions are studied.


What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 273,308 Gabapentin users for its effectiveness, alternative drugs and more.

What is Daklinza?

Daklinza has active ingredients of daclatasvir dihydrochloride. eHealthMe is studying from 3,303 Daklinza users for its effectiveness, alternative drugs and more.

Number of Gabapentin and Daklinza reports submitted per year:

Gabapentin and Daklinza drug interactions.

Common Gabapentin and Daklinza drug interactions by gender *:

female:

  1. Fatigue
  2. Nausea
  3. Pain in extremity
  4. Depression
  5. Feeling hot
  6. Headache
  7. Insomnia
  8. Crying
  9. Pneumonia
  10. Dizziness

male:

  1. Diarrhoea
  2. Fatigue
  3. Abdominal pain lower
  4. Anxiety
  5. Conjunctivitis viral
  6. Constipation
  7. Dehydration
  8. Hepatic encephalopathy
  9. Gastritis alcoholic
  10. Hepatitis alcoholic

Common Gabapentin and Daklinza drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anxiety
  2. Asthenia
  3. Depression
  4. Fatigue
  5. Headache
  6. Hypoaesthesia
  7. Loss of consciousness
  8. Memory impairment
  9. Migraine
  10. Nervousness

40-49:

  1. Pneumonia
  2. Feeling hot
  3. Insomnia
  4. Pain in extremity
  5. Abdominal distension
  6. Constipation
  7. Crying
  8. Depression
  9. Abdominal pain lower
  10. Conjunctivitis viral

50-59:

  1. Diarrhoea
  2. Asthenia
  3. Cough
  4. Flatulence
  5. Muscle spasms
  6. Epistaxis
  7. Pollakiuria
  8. Thirst
  9. Vomiting
  10. Gastritis alcoholic

60+:

  1. Fatigue
  2. Hepatic pain
  3. Nausea
  4. Pneumonia
  5. Chronic obstructive pulmonary disease
  6. Dehydration
  7. Gastric disorder

Common conditions people have *:

  1. Hepatitis C: 26 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Daklinza?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Gabapentin and Daklinza interactions:

Browse all drug interactions of Gabapentin and Daklinza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gabapentin side effects:

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Daklinza side effects:

Browse all side effects of Daklinza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gabapentin interactions:

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Daklinza interactions:

Browse all interactions between Daklinza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and daclatasvir dihydrochloride (the active ingredients of Gabapentin and Daklinza, respectively), and Gabapentin and Daklinza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gabapentin and Daklinza.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: